Manufacturer of Controlled Substances; Notice of Registration, 47232-47233 [05-15970]

Download as PDF 47232 Federal Register / Vol. 70, No. 155 / Friday, August 12, 2005 / Notices Y.C.C. did not file a response. On July 14, 2005, the presiding ALJ issued the subject ID, granting the motion for termination. No petitions for review of the ID were filed. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in section 210.42(h)(3) of the Commission’s Rules of Practice and Procedure (19 CFR 210.42(h)(3)). Issued: August 9, 2005. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. 05–16057 Filed 8–11–05; 8:45 am] Register pursuant to Section 6(b) of the Act on May 26, 2005 (70 FR 30485). DEPARTMENT OF JUSTICE Dorothy B. Fountain, Deputy Director of Operations, Antitrust division. [FR Doc. 05–15982 Filed 8–11–05; 8:45 am] Manufacturer of Controlled Substances; Notice of Application BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. BILLING CODE 7020–02–U DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Interchangeable Virtual Instruments Foundation, Inc. Notice is hereby given that, on July 20, 2005, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’). Interchangeable Virtual Instruments Foundation, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Pickering Interfaces, Ltd., Essex, England, United Kingdom has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Interchangeable Virtual Instruments Foundation, Inc. intends to file additional written notification disclosing all changes in membership. On May 29, 2001, Interchangeable Virtual Instruments Foundation, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 30, 2001 (66 FR 39336). The last notification was filed with the Department on May 2, 2005. A notice was published in the Federal VerDate jul<14>2003 17:14 Aug 11, 2005 Jkt 205001 Notice is hereby given that, on July 20, 2005, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), PXI Systems Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Triple E Corp., Lowell, MA has been added as a party to this venture. Also, BAE Systems, San Diego, CA; Team Solutions, Mission Viejo, CA; and SRC Corporation, Tokyo, JAPAN have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PXI Systems Alliance, Inc. intends to file additional written notification disclosing all changes in membership. On November 22, 2000, PXI Systems Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on March 8, 2001 (66 FR 13971). The last notification was filed with the Department on May 2, 2005. A notice was published in the Federal Register pursuant to section 6(b) of the Act on May 26, 2005 (70 FR 30486). Dorothy B. Fountain, Deputy Director of Operations, Antitrust Division. [FR Doc. 05–15983 Filed 8–11–05; 8:45 am] BILLING CODE 4410–11–M PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 Drug Enforcement Administration Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 8, 2005, National Center for Natural Products Research, University of Mississippi, 135 Coy Waller Lab Complex, University, Mississippi 38677, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic class of controlled substances listed in Schedule I: Drug Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Schedule I I The company plans to bulk manufacture the controlled substances to prepare marihuana extract for further purification into bulk active delta-9THC for use in launching FDA approved pharmaceutical products. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than October 11, 2005. Dated: August 5, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–15971 Filed 8–11–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated February 23, 2005, and published in the Federal Register E:\FR\FM\12AUN1.SGM 12AUN1 Federal Register / Vol. 70, No. 155 / Friday, August 12, 2005 / Notices on March 7, 2005, (70 FR 11032), Norac, Inc., 405 S. Motor Avenue, PO Box 577, Azusa, California 91702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Tetrahydrocannabinols (7370), a basic class of controlled substance listed in Schedule I. The company plans to manufacture the listed controlled substance in bulk for formulation into the pharmaceutical product Marinol. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Norac, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Norac, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: August 3, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–15970 Filed 8–11–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Executive Office for Immigration Review Agency Information Collection Activities: Proposed Collection; Comments Requested 30-day notice of information collection under review: fee waiver request. ACTION: The Department of Justice (DOJ), Executive Office for Immigration Review (EOIR) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously VerDate jul<14>2003 17:14 Aug 11, 2005 Jkt 205001 published in the Federal Register Volume 70, Number 103, page 30974 on May 31, 2005, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until September 12, 2005. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this Information Collection (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Fee Waiver Request. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form Number: Form EOIR 26A. Executive Office for Immigration Review. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary An individual submitting an appeal or motion to the Board of Immigration Appeals. Other: None. Abstract: The information on the PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 47233 fee waiver request form is used by the Board of Immigration Appeals to determine whether the requisite fee for a motion or appeal will be waived due to an individual’s financial situation. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply: It is estimated that 1,500 respondents will complete the form annually with an average of one hour per response. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 1,500 total burden hours associated with this collection annually. If additional information is required contact: Brenda E. Dyer, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street NW., Washington, DC 20530. Dated: August 9, 2005. Brenda E. Dyer, Department Clearance Officer, Department of Justice. [FR Doc. 05–16042 Filed 8–11–05; 8:45 am] BILLING CODE 4410–30–U DEPARTMENT OF JUSTICE Executive Office for Immigration Review [EOIR No. 151] Notice of Relocation Executive Office for Immigration Review. ACTION: Notice AGENCY: SUMMARY: Notice is hereby given that the Office of the Clerk of the Board of Immigration Appeals, Executive Office for Immigration Review, is moving to a new location. EFFECTIVE DATE: This notice is effective August 29, 2005. FOR FURTHER INFORMATION CONTACT: MaryBeth Keller, General Counsel, Executive Office for Immigration Review, 5107 Leesburg Pike, Suite 2600, Falls Church, Virginia 22041, (703) 305– 0470. SUPPLEMENTARY INFORMATION: The new street address for the Office of the Clerk is: 5107 Leesburg Pike, Suite 2000, Falls Church, VA 22041. The mailing address is: Office of the Clerk, P.O. Box 8530, Falls Church, VA 22041. The main telephone namer is (703) 605–1007. Public window hours are 8 a.m. to 4:30 p.m. The Internet site for all components of the Executive Office for E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 70, Number 155 (Friday, August 12, 2005)]
[Notices]
[Pages 47232-47233]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15970]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 23, 2005, and published in the Federal 
Register

[[Page 47233]]

on March 7, 2005, (70 FR 11032), Norac, Inc., 405 S. Motor Avenue, PO 
Box 577, Azusa, California 91702, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Tetrahydrocannabinols (7370), a basic class of 
controlled substance listed in Schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for formulation into the pharmaceutical product Marinol.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Norac, Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Norac, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic class of controlled substance listed.

    Dated: August 3, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-15970 Filed 8-11-05; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.